Eric M Ammann

17PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyDisease surveillanceNatural language processingMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 17, 2026
Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma.

Meletios A Dimopoulos, Mario Boccadoro, Hermann Einsele

|Jun 11, 2025
Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States.

Lucio N Gordan, Arielle G Bensimon, Fan Mu

|Aug 03, 2023
Epidemiology and clinical outcomes of light-chain amyloidosis in Sweden: A nationwide population-based study.

Ulf-Henrik Mellqvist, Qian Cai, Laura L Hester

|Nov 21, 2022
Validation of an administrative coding algorithm for the identification of individuals with amyloid light chain amyloidosis using administrative data.

Victor H Jimenez-Zepeda, Donna Reece, Rodrigo Rigo

|Oct 25, 2022
Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases.

Angela Dispenzieri, Jeffrey Zonder, James Hoffman

|Jun 28, 2022
Correction to: Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.

Thierry Facon, Jesús San-Miguel, Meletios A Dimopoulos

Pageof 3

Frequent Collaborators

2 joint publications

Elizabeth A Chrischilles

2 joint publications

Scott K Winiecki

2 joint publications

Charles E Leonard

2 joint publications

Ryan M Carnahan